7 results
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... modifications Metformin ... Sulfonylureas GLP ... -1 receptor agonists
Effects on body weight of various classes of type-2 diabetes medications.
 - Metformin - Weight Loss
weight of various classes ... of type-2 diabetes ... - Metformin - ... Weight Loss ++ - GLP ... weightgain #comparison #pharmacology
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
- Pharmacology ... Summary Mechanisms ... receptor agonist ... not definitively cause ... Summary #DM2 #diabetes
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... - Pharmacology ... Summary Mechanisms ... side effects (e.g ... Summary #DM2 #diabetes
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Medication Guide Classes ... , GLP-1 receptor ... α-glucosidase inhibitor ... 0.3-0.6 units/kg ... #Medications #pharmacology
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... Summary Mechanisms ... side effects (e.g ... #Pharmacology # ... Summary #DM2 #diabetes
Vasopressors and Inotropes - Pharmacology Summary
Vasopressors
Phenylephrine (alpha-1)
 • Increases BP, SVR
 • Risk of reflex bradycardia
and Inotropes - Pharmacology ... Summary Vasopressors ... • Higher doses cause ... Dose dependent receptor ... Phosphodiesterase inhibitor